Derivation and characterization of retinal pigment epithelium from urine‐derived iPSCs
FEBS Open Bio · 2026-09 · 16 (9) · 1691-1707
DOI: 10.1002/2211-5463.70246 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, online erschienen am 24.04.2026. Verfasst von Daniella Beiner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wake Forest Institute for Regeneration Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. Hauptthemen laut MEDLINE: Retinal Pigment Epithelium, Induced Pluripotent Stem Cells, Urine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Translational Eye and Vision Research Center (TrEVR), Wake Forest School of Medicine (WFSM), Eye Bank Association of America (EBAA), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID, NIH).
Abstract (Originalsprache)
Age‐related macular degeneration (AMD), particularly its dry form, is a leading cause of irreversible vision loss due to retinal pigment epithelium (RPE) dysfunction and loss. Addressing this unmet therapeutic need requires non‐invasive strategies for generating patient‐specific RPE cells. This study reports the successful generation and initial characterization of RPE cells derived from urine‐derived induced pluripotent stem cells (u‐iPSC‐RPE). Urine‐derived stem cells (USCs) were isolated from healthy individuals and comprehensively characterized, confirming strong expression of renal progenitor makers and mesenchymal stem cell markers, while lacking standard hematopoietic markers. USCs were reprogrammed into iPSCs using the integration‐free Sendai virus expressing the Yamanaka factors. The reprogrammed u‐iPSC clones displayed characteristic pluripotency marker expression and demonstrated clearance of the Sendai virus by later passages. Subsequently, these u‐iPSCs were efficiently differentiated into RPE cells, exhibiting characteristic hexagonal morphology and pigmentation which was confirmed by the expression of key RPE‐specific proteins. Our findings demonstrate the feasibility and reliability of generating patient‐specific u‐iPSC‐RPE cells from readily accessible USCs providing a foundation for future studies to investigate their functional potential for retinal disease modeling and therapeutic applications for AMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wake Forest Institute for Regeneration Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
- Combat Casualty Care & Operational Medicine, Naval Medical Research Unit-San Antonio (NAMRU-SA), TX, USA.
- Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA.
ORCID-Profile: Yuanyuan Zhang
Förderung
- Translational Eye and Vision Research Center (TrEVR), Wake Forest School of Medicine (WFSM)
- Eye Bank Association of America (EBAA)
- National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID, NIH)
- Wake Forest School of Medicine (WFSM)
- NEI NIH HHS
- NIAID NIH HHS
- Department of Defense
- U.S. Department of Defense
Zitieren
APA
Beiner, D., Zhu, H., Bosholm, C. C., Wang, H. C., Criswell, T., Atala, A., Ma, J. X., & Zhang, Y. (2026). Derivation and characterization of retinal pigment epithelium from urine‐derived iPSCs. FEBS Open Bio, 16(9), 1691-1707. https://doi.org/10.1002/2211-5463.70246
Vancouver
Beiner D, Zhu H, Bosholm CC, Wang HC, Criswell T, Atala A, et al. Derivation and characterization of retinal pigment epithelium from urine‐derived iPSCs. FEBS Open Bio. 2026;16(9):1691-1707. doi:10.1002/2211-5463.70246
BibTeX
@article{Beiner2026,
author = {Beiner, Daniella and Zhu, Hainan and Bosholm, Carol Christine and Wang, Heuy-Ching and Criswell, Tracy and Atala, Anthony and Ma, Jian-Xing and Zhang, Yuanyuan},
title = {Derivation and characterization of retinal pigment epithelium from urine‐derived iPSCs},
journal = {FEBS Open Bio},
year = {2026},
volume = {16},
number = {9},
pages = {1691--1707},
doi = {10.1002/2211-5463.70246}
}
EUVIMED